ArticleCancer research and treatment2023

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study.

Taeyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.